Ilir Agalliu1, Xiaonan Xue1, Mary Cushman2, Elaine Cornell3, Ann W Hsing4, Robert C Kaplan1, Kathryn Anastos5, Swapnil Rajpathak6, Gloria Y F Ho1. 1. Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA. 2. Department of Medicine, University of Vermont, Colchester, VT, USA. 3. Department of Pathology, University of Vermont, Colchester, VT, USA. 4. Cancer Prevention Institute of California, Freemont, CA, USA ; Stanford Cancer Institute, Palo Alto, CA, USA. 5. Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA ; Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, USA. 6. Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA ; Current address: Merck & Co., Inc., Whitehouse Station, NJ, USA.
Abstract
BACKGROUND: Multiplex assays are available to measure an array of circulating chemokines, soluble cytokine receptors and growth factors. However, there is limited information regarding whether these analytes are suitable for large-scale epidemiological studies to assess their relationships with chronic diseases, including cancer. METHODS: We examined detectability, assay repeatability, and 3-year within-subject reproducibility of plasma levels of 25 chemokines and 11 soluble receptors of cytokines and growth factors selected from the Human Millipore Panels. Plasma samples were obtained from 36 men (average age 62 years) and 17 women (average age 32 years) who participated in two epidemiological studies. Inter-assay and within-subject reproducibility were assessed by intraclass correlation coefficients (ICC). RESULTS: All analytes, except lymphotactin (47% detectability), were detectable in >90% of plasma samples. Inter-assay reproducibility for all analytes in 36 men tested three times on separate days were good to excellent (ICCs: 0.71-1.00). Within-subject reproducibility in 17 women sampled three times in three years were excellent (ICC ≥ 0.75) for five chemokines (eotaxin, fractalkine, 6Ckine, eotaxin 3, and SDF-1α+β) and three soluble receptors (sIL-1R2, sIL-4R and sVEGFR2); ICCs were fair to good (0.4 ≤ ICC < 0.75) for 15 chemokines and eight soluble receptors. However, five chemokines (GRO, IP-10, MIP-1β, BCA-1, and MIP-3α) had ICC < 0.4, suggesting biological variability. CONCLUSION: Multiplex assays for plasma levels of selected chemokines and soluble receptors showed good to excellent assay detectability and repeatability. Most analytes also had good 3-year within-subject reproducibility, indicating that a single measurement of these analytes may be used to assess biomarker-disease associations.
BACKGROUND: Multiplex assays are available to measure an array of circulating chemokines, soluble cytokine receptors and growth factors. However, there is limited information regarding whether these analytes are suitable for large-scale epidemiological studies to assess their relationships with chronic diseases, including cancer. METHODS: We examined detectability, assay repeatability, and 3-year within-subject reproducibility of plasma levels of 25 chemokines and 11 soluble receptors of cytokines and growth factors selected from the Human Millipore Panels. Plasma samples were obtained from 36 men (average age 62 years) and 17 women (average age 32 years) who participated in two epidemiological studies. Inter-assay and within-subject reproducibility were assessed by intraclass correlation coefficients (ICC). RESULTS: All analytes, except lymphotactin (47% detectability), were detectable in >90% of plasma samples. Inter-assay reproducibility for all analytes in 36 men tested three times on separate days were good to excellent (ICCs: 0.71-1.00). Within-subject reproducibility in 17 women sampled three times in three years were excellent (ICC ≥ 0.75) for five chemokines (eotaxin, fractalkine, 6Ckine, eotaxin 3, and SDF-1α+β) and three soluble receptors (sIL-1R2, sIL-4R and sVEGFR2); ICCs were fair to good (0.4 ≤ ICC < 0.75) for 15 chemokines and eight soluble receptors. However, five chemokines (GRO, IP-10, MIP-1β, BCA-1, and MIP-3α) had ICC < 0.4, suggesting biological variability. CONCLUSION: Multiplex assays for plasma levels of selected chemokines and soluble receptors showed good to excellent assay detectability and repeatability. Most analytes also had good 3-year within-subject reproducibility, indicating that a single measurement of these analytes may be used to assess biomarker-disease associations.
Entities:
Keywords:
Biomarker; Chemokines; Limit of detection; Soluble receptors; Within-subject variability
Authors: Anil K Chaturvedi; Troy J Kemp; Ruth M Pfeiffer; Angelique Biancotto; Marcus Williams; Stella Munuo; Mark P Purdue; Ann W Hsing; Ligia Pinto; J Philip McCoy; Allan Hildesheim Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-06-29 Impact factor: 4.254
Authors: Gloria Y F Ho; Xiao-Nan Xue; Robert D Burk; Robert C Kaplan; Elaine Cornell; Mary Cushman Journal: Cytokine Date: 2005-04-07 Impact factor: 3.861
Authors: Tess V Clendenen; Alan A Arslan; Anna E Lokshin; Annika Idahl; Göran Hallmans; Karen L Koenig; Adele M Marrangoni; Brian M Nolen; Nina Ohlson; Anne Zeleniuch-Jacquotte; Eva Lundin Journal: BMC Res Notes Date: 2010-11-13
Authors: Heather S McKay; Joseph B Margolick; Otoniel Martínez-Maza; Joseph Lopez; John Phair; Giovanna Rappocciolo; Thomas N Denny; Larry I Magpantay; Lisa P Jacobson; Jay H Bream Journal: Cytokine Date: 2016-12-09 Impact factor: 3.861
Authors: Gloria Y F Ho; Tao Wang; Siqun L Zheng; Lesley Tinker; Jianfeng Xu; Thomas E Rohan; Sylvia Wassertheil-Smoller; Xiaonan Xue; Leonard H Augenlicht; Ulrike Peters; Amanda I Phipps; Howard D Strickler; Marc J Gunter; Mary Cushman Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-11-05 Impact factor: 4.254
Authors: Paul A Dennis; J Brice Weinberg; Patrick S Calhoun; Lana L Watkins; Andrew Sherwood; Michelle F Dennis; Jean C Beckham Journal: J Psychosom Res Date: 2016-02-26 Impact factor: 3.006
Authors: Martin Trapecar; Emile Wogram; Devon Svoboda; Catherine Communal; Attya Omer; Tenzin Lungjangwa; Pierre Sphabmixay; Jason Velazquez; Kirsten Schneider; Charles W Wright; Samuel Mildrum; Austin Hendricks; Stuart Levine; Julien Muffat; Meelim Jasmine Lee; Douglas A Lauffenburger; David Trumper; Rudolf Jaenisch; Linda G Griffith Journal: Sci Adv Date: 2021-01-29 Impact factor: 14.136
Authors: Julia Hoefer; Markus Luger; Christian Dal-Pont; Zoran Culig; Harald Schennach; Stefan Jochberger Journal: Front Aging Neurosci Date: 2017-12-01 Impact factor: 5.750
Authors: Megan B Vogt; Anismrita Lahon; Ravi P Arya; Alexander R Kneubehl; Jennifer L Spencer Clinton; Silke Paust; Rebecca Rico-Hesse Journal: PLoS Negl Trop Dis Date: 2018-05-17